Abstract
The bromodomain (BrD), a conserved structural module found in many chromatin- and transcription-associated proteins, is the primary reader of acetylated lysine residues on proteins. Since the discovery of this domain, the study of BrD-containing proteins has provided tremendous insights into many important mechanisms in chromatin biology and also shown that inhibitors of BrDs can be useful both as chemical tools in the laboratory and as therapeutics in the clinic. BrDs often function in concert with other similar modular domains on chromatin-associated proteins, creating a very complex system of epigenetic regulation that is currently under investigation by numerous researchers. In this chapter, we take a closer look at the structure and functions of the BrD, as well as its interaction with other chromatin-associated modules and its overall role in disease biology.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Albrecht BK, Audia JE, Cote A, Gehling VS, Harmange J-C, Hewitt MC, LeBlanc Y, Naveschuk CG, Taylor AM, Vaswani RG (2014) Inventors; constellation pharmaceuticals, Inc., assignee. Bromodomain Inhibitors and Uses Thereof. USA2012
Anand P, Brown JD, Lin CY, Qi J, Zhang R, Artero PC, Alati MA, Bullard J, Alazem K, Margulies KB, Cappola TP, Lemieux M, Plutzky J, Bradner JE, Haldar SM (2013) BET bromodomains mediate transcriptional pause release in heart failure. Cell 154:569–582
Asangani IA, Dommeti VL, Wang X, Malik R, Cieslik M, Yang R, Escara-Wilke J, Wilder-Romans K, Dhanireddy S, Engelke C, Iyer MK, Jing X, Wu Y-M, Cao X, Qin ZS, Wang S, Feng FY, Chinnaiyan AM (2014) Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer. Nature 510(7504):278–282
Bamborough P, Diallo H, Goodacre JD, Gordon L, Lewis A, Seal JT, Wilson DM, Woodrow MD, Chung C-W (2012) Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides. J Med Chem 55:587–596
Bannister AJ, Kouzarides T (2005) Reversing histone methylation. Nature 436(7054):1103–1106
Basu MK, Carmel L, Rogozin IB, Koonin EV (2008) Evolution of protein domain promiscuity in eukaryotes. Genome Res 18(3):449–461
Basu MK, Poliakov E, Rogozin IB (2009) Domain mobility in proteins: functional and evolutionary implications. Brief Bioinform 10(3):205–216
Becker PB, Workman JL (2013) Nucleosome remodeling and epigenetics. Cold Spring Harb Perspect Biol 5(9):1–19
Belkina AC, Denis GV (2012) BET domain co-regulators in obesity, inflammation and cancer. Nat Rev Cancer 12:465–477
Boehm D, Calvanese V, Dar RD, Xing S, Schroeder S, Martins L, Aull K, Li P-C, Planelles V, Bradner JE, Zhou M-M, Siliciano RF, Weinberger L, Verdin E, Ott M (2013) BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism. Cell Cycle 12(3):452–462
Borah JC, Mujtaba S, Karakikes I, Zeng L, Muller M, Patel J, Moshkina N, Morohashi K, Zhang W, Gerona-Navarro G, Hajjar RJ, Zhou M-M (2011) A small molecule binding to the coactivator CREB-binding protein blocks apoptosis in cardiomyocytes. Chem Biol 18:531–541
Capili AD, Schultz DC III (2001) FJR, borden KLB. Solution structure of the PHD domain from the KAP-1 corepressor: structural determinants for PHD, RING and LIM zinc-binding domains. EMBO J 20(1):165–177
Carlsten JOP, Zhu X, Gustafsson CM (2013) The multitalented mediator complex. Trends Biochem Sci 38(11):531–537
Cheng Z, Gong Y, Ma Y, Lu K, Lu X, Pierce LA, Thompson RC, Muller S, Knapp S, Wang J (2013) Inhibition of BET bromodomain targets genetically diverse glioblastoma. Clin Cancer Res 19(7):1–12
Chi P, Allis CD, Wang GG (2010) Covalent histone modifications—miswritten, misinterpreted and MIS-erased in human cancers. Nature Reviews 10(7):457–69; PubMed Central PMCID: PMC3262678
Chiang C-M (2009) Brd4 engagement from chromatin targeting to transcriptional regulation: selective contact with acetylated histone H3 and H4. F1000 Biol Rep 1
Chou K-C, Maggiora GM, Nemethy G, Scheraga HA (1988) Energetics of the structure of the four-alpha-helix bundle in proteins. Proc Natl Acad Sci USA 85:4295–4299
Chung C-W, Dean AW, Woolven JM, Bamborough P (2012) Fragment-based discovery of bromodomain inhibitors part 1: inhibitor binding modes and implications for lead discovery. J Med Chem 55:576–586
Clapier CR, Cairns BR (2009) The biology of chromatin remodeling complexes. Annu Rev Biochem 78:273–304
Conaway RC, Conaway JW (2011) Function and regulation of the mediator complex. Curr Opin Genet Dev 21(2):225–230
Crawford NPS, Alsarraj J, Lukes L, Walker RC, Officewala JS, Yang HH, Lee MP, Ozato K, Hunter KW (2008) Bromodomain 4 activation predicts breast cancer survival. Proc Natl Acad Sci USA 105(17):6380–6385
Dawson MA, Prinjha RK, Dittmann A, Giotopoulos G, Bantscheff M, Chan W-I, Robson SC, Chung C-w, Hopf C, Savitski MM, Huthmacher C, Gudgin E, Lugo D, Beinke S, Chapman TD, Roberts EJ, Soden PE, Auger KR, Mirguet O, Doehner K, Delwel R, Burnett AK, Jeffrey P, Drewes G, Lee K, Huntly BJP, Kouzarides T (2011) Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 478:529–533; PubMed Central PMCID: PMC3679520
Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, Jacobs HM, Kastritis E, Gilpatrick T, Paranal RM, Qi J, Chesi M, Schinzel AC, McKeown MR, Heffernan TP, Vakoc CR, Bergsagel PL, Ghobrial IM, Richardson PG, Young RA, Hahn WC, Anderson KC, Kung AL, Bradner JE, Mitsiades CS (2011) BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146:904–917; PubMed Central PMCID: PMC3187920
Delvecchio M, Gaucher J, Aguilar-Gurrieri C, Ortega E, Panne D (2013) Structure of the p300 catalytic core and implications for chromatin targeting and HAT regulation. Nat Struct Mol Biol 20(9):1040–1046
Devaiah BN, Lewis BA, Cherman N, Hewitt MC, Albrecht BK, Robey PG, Ozato K, Robert J. Sims I, Singer DS (2012) BRD4 is an atypical kinase that phosphorylates serine2 of the RNA polymerase II carboxy-terminal domain. Proc Natl Acad Sci USA 109(18):6927–6932
Dey A, Ellenberg J, Farina A, Coleman AE, Maruyama T, Sciortino S, Lippincott-Schwartz J, Ozato K (2000) A bromodomain protein, MCAP, associates with mitotic chromosomes and affects G2-to-M transition. Mol Cell Biol 20(17):6537–6549
Dey A, Chitsaz F, Abbasi A, Misteli T, Ozato K (2003) The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proc Natl Acad Sci USA 100(15):8758–8763
Dey A, Nishiyama A, Karpova T, McNally J, Ozato K (2009) Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription. Mol Biol Cell 20:4899–4909
Dhalluin C, Carlson JE, Zeng L, He C, Aggarwal AK, Zhou M-M (1999) Structure and ligand of a histone acetyltransferase bromodomain. Nature 399:491–496
Filippakopoulos P, Knapp S (2012) The bromodomain interaction module. FEBS Lett 586(17):2692–2704
Filippakopoulos P, Knapp S (2014) Targeting bromodomains: epigenetic readers of lysine acetylation. Nat Rev Drug Disc Epub 22 April 2014. doi: 10.1038/nrd4286
Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, Morse EM, Keates T, Hickman TT, Felletar I, Philpott M, Munro S, McKeown MR, Wang Y, Christie AL, West N, Cameron MJ, Schwartz B, Heightman TD, Thangue NL, French CA, Wiest O, Kung AL, Knapp S, Bradner JE (2010) Selective inhibition of BET bromodomains. Nature 468:1067–1073; PubMed Central PMCID: PMC3010259
Filippakopoulos P, Picaud S, Mangos M, Keates T, Lambert J-P, Barsyte-Lovejoy D, Felletar I, Volkmer R, Muller S, Pawson T, Gingras A-C, Arrowsmith CH, Knapp S (2012) Histone recognition and large-scale structural analysis of the human bromodomain family. Cell 149:214–231
Floyd SR, Pacold ME, Huang Q, Clarke SM, Lam FC, Cannell IG, Bryson BD, Rameseder J, Lee MJ, Blake EJ, Fydrych A, Ho R, Greenberger BA, Chen GC, Maffa A, Rosario AMD, Root DE, Carpenter AE, Hahn WC, Sabatini DM, Chen CC, White FM, Bradner JE, Yaffe MB (2013) The bromodomain protein Brd4 insulates chromatin from DNA damage signalling. Nature 498(7453):246–250
French CA, Miyoshi I, Aster JC, Kubonishi I, Kroll TG, Cin PD, Vargas SO, Perez-Atayde AR, Fletcher JA (2001) BRD4 Bromodomain gene rearrangement in aggressive carcinoma with translocation t(15;19). Am J Pathol 159(6):1987–1992
French CA, Miyoshi I, Kubonishi I, Grier HE, Perez-Atayde AR, Fletcher JA (2003) BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma. Cancer Res 63:304–307
French C, Ramirez C, Kolmakova J, Hickman T, Cameron M, Thyne M, Kutok J, Toretsky J, Tadavarthy A, Kees U, Fletcher J, Aster J (2008) BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells. Oncogene 27:2237–2242
Fuda NJ, Ardehali MB, Lis JT (2009) Defining mechanisms that regulate RNA polymerase II transcription in vivo. Nature 461:186–192
Gacias M, Gerona-Navarro G, Plotnikov AN, Zhang G, Zeng L, Kaur J, Moy G, Rusinova E, Rodriguez Y, Matikainen B, Vincek A, Joshua J, Casaccia P, Zhou M-M (2014) Selective chemical modulation of gene transcription favors oligodendrocyte lineage progression. Chem Biol 21:841–854
Gagnon D, Joubert S, Senechal H, Fradet-Turcotte A, Torre S, Archambault J (2009) Proteasomal degradation of the papillomavirus E2 protein is inhibited by overexpression of bromodomain-containing protein 4. J Virol 83(9):4127–4139
Gamsjaeger R, Webb SR, Lamonica JM, Billin A, Blobel GA, Mackay JP (2011) Structural basis and specificity of acetylated transcription factor GATA1 recognition by BET family bromodomain protein Brd3. Mol Cell Biol 31(13):2632–2640
Gerona-Navarro G, Rodriguez Y, Mujtaba S, Frasca A, Patel J, Zeng L, Plotnikov AN, Osman R, Zhou M-M (2011) Rational design of cyclic peptide modulators of the transcriptional coactivator CBP: a new class of p53 inhibitors. J Am Chem Soc 133:2040–2043
Gil J, Bernard D, Martinez D, Beach D (2004) Polycomb CBX7 has a unifying role in cellular lifespan. Nat Cell Biol 6(1):67–72
Gilmore TD (1999) The Rel/NF-KB signal transduction pathway: introduction. Oncogene 18:6842–6844
Gregory GD, Vakoc CR, Rozovskaia T, Zheng X, Patel S, Nakamura T, Canaani E, Blobel GA (2007) Mammalian ASH1L is a histone methyltransferase that occupies the transcribed region of active genes. Mol Cell Biol 27(24):8466–8479
Harikrishnan KN, Chow MZ, Baker EK, Pal S, Bassal S, Brasacchio D, Wang L, Craig JM, Jones PL, Sif S, El-Osta A (2005) Brahman links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing. Nat Genet 37(3):254–264
Hassan AH, Prochasson P, Neely KE, Galasinski SC, Chandy M, Carrozza MJ, Workman JL (2002) Function and selectivity of Bromodomains in anchoring chromatin-modifying complexes to promoter nucleosomes. Cell 111:369–379
Hassan AH, Awad S, Prochasson P (2006) The Swi2/Snf2 Bromodomain Is required for the displacement of SAGA and the octamer transfer of SAGA-acetylated nucleosomes. J Biol Chem 281(26):18126–18134
Hayden MS, Ghosh S (2004) Signaling to NF-KB. Genes Dev 18:2195–2224
Hewings DS, Wang M, Philpott M, Fedorov O, Uttarkar S, Filippakopoulos P, Picaud S, Vuppusetty C, Marsden B, Knapp S, Conway SJ, Heightman TD (2011) 3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands. J Med Chem 54:6761–6770
Hnisz D, Abraham BJ, Lee TI, Lau A, Saint-Andre V, Sigova AA, Hoke HA, Young RA (2013) Super-enhancers in the control of cell identity and disease. Cell 155:934–947
Hoffmann A, Natoli G, Ghosh G (2006) Transcriptional regulation via the NF-KB signaling module. Oncogene 25:6706–6716
Horn P, Peterson C (2001) The bromodomain: a regulator of ATP-dependent chromatin remodeling? Front Biosci 6:D1019–D1023
Huang B, Yang X-D, Zhou M-M, Ozato K, Chen L-F (2009) Brd4 coactivates transcriptional activation of NF-KB via specific binding to acetylated RelA. Mol Cell Biol 29(5):1375–1387
Ivanov AV, Peng H, Yurchenko V, Yap KL, Negorev DG, Schultz DC, Psulkowski E, Fredericks WJ, White DE, Maul GG, Sadofsky MJ, Zhou M-M III (2007) FJR. PHD Domain-mediated E3 ligase activity directs intramolecular sumoylation of an adjacent bromodomain required for gene silencing. Mol Cell 28:823–837
Jacobson RH, Ladurner AG, King DS, Tijan R (2000) Structure and function of a human TAF(II)250 double bromodomain module. Science 288:1422–1425
Jang MK, Mochizuki K, Zhou M, Jeong H-S, Brady JN, Ozato K (2005) The bromodomain protein Brd4 Is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Mol Cell 19:523–534
Jeanmougin F, Wurtz J-M, Douarin BL, Chambon P, Losson R (1997) The bromodomain revisited. Trends Biochem Sci 22(5):151–153
Josling GA, Selvarajah SA, Petter M, Duffy MF (2012) The role of bromodomain proteins in regulating gene expression. Genes 3:320–343
Kagey MH, Newman JJ, Bilodeau S, Zhan Y, Orlando DA, Berkum NL, Ebmeier CC, Goossens J, Rahl PB, Levine SS, Taatjes DJ, Dekker J, Young RA (2010) Mediator and cohesion connect gene expression and chromatin architecture. Nature 467:430–435
Kouzarides T (2007) Chromatin modifications and their function. Cell 128(4):693–705
Li H, Ilin S, Wang W, Duncan EM, Wysocka J, Allis CD, Patel DJ (2006) Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF. Nature 442(7098):91–95
Li Y, Wen H, Xi Y, Tanaka K, Wang H, Peng D, Ren Y, Jin Q, Dent SYR, Li W, Li H, Shi X (2014) AF9 YEATS domain links histone acetylation to DOT1L-Mediated H3K79 methylation. Cell 159:558–571
Lin Y-J, Umehara T, Inoue M, Saito K, Kigawa T, Jang M-K, Ozato K, Yokoyama S, Padmanabhan B, Guntert P (2008) Solution structure of the extraterminal domain of the bromodomain-containing protein BRD4. Protein Sci 17:2174–2179
Lucas X, Wohlwend D, Hugle M, Schmidtkunz K, Gerhardt S, Schule R, Jung M, Einsle O, Gunther S (2013) 4-acyl pyrroles: mimicking acetylated lysines in histone code reading. Angew Chem Int Ed 52:14055–14059
Mele DA, Salmeron A, Ghosh S, Huang H-R, Bryant BM, Lora JM (2013) BET bromodomain inhibition suppresses TH17-mediated pathology. J Exp Med 210(11):2181–2190
Mertz JA, Conery AR, Bryant BM, Sandy P, Balasubramanian S, Mele DA, Bergeron L, III RJS (2011) Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proc Natl Acad Sci USA 108(40):16669–16674; PubMed Central PMCID: PMC3189078
Meslamani J, Smith SG, Sanchez R, Zhou M-M (2014) ChEpiMod: a knowledgebase for chemical modulators of epigenome reader domains. Bioinformatics 30(10):1481–1483
Mills AA (2010) Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins. Nat Rev Cancer 10:669–682
Milne TA, Briggs SD, Brock HW, Martin ME, Gibbs D, Allis CD, Hess JL (2002) MLL targets set domain methyltransferase activity to hox gene promoters. Mol Cell 10(5):1107–1117
Mirguet O, Lamotte Y, Donche Fdr, Toum Jrm, Gellibert Fo, Bouillot A, Gosmini R, Nguyen V-L, Delannée D, Seal J, Blandel F, Boullay A-Bnd, Boursier E, Martin S, Brusq J-M, Krysa G, Riou A, Tellier Rm, Costaz As, Huet P, Dudit Y, Trottet L, Kirilovsky J, Nicodeme E (2012) From ApoA1 upregulation to BET family bromodomain inhibition: discovery of I-BET151. Bioorg Med Chem Lett 22:2963–2967
Mochizuki K, Nishiyama A, Jang MK, Dey A, Ghosh A, Tamura T, Natsume H, Yao H, Ozato K (2008) The bromodomain protein Brd4 stimulates G1 gene transcription and promotes progression to S phase. J Biol Chem 283(14):9040–9048
Moriniere J, Rousseaux S, Steuerwald U, Soler-Lopez M, Curtet S, Vitte A-L, Govin J, Gaucher J, Sadoul K, Hart DJ, Krijgsveld J, Khochbin S, Muller CW, Petosa C (2009) Cooperative binding of two acetylation marks on a histone tail by a single bromodomain. Nature 461(7264):664–668
Mujtaba S, He Y, Zeng L, Farooq A, Carlson JE, Ott M, Verdin E, Zhou M-M (2002) Structural basis of lysine-acetylated HIV-1 tat recognition by PCAF bromodomain. Mol Cell 9(3):575–586
Mujtaba S, He Y, Zeng L, Yan S, Plotnikova O, Sachchidanand, Sanchez R, Zeleznik-Le NJ, Ronai Ze, Zhou M-M (2004) Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation. Mole Cell 13:251–263
Nicodeme E, Jeffrey KL, Schaefer U, Beinke S, Dewell S, Chung C-w, Chandwani R, Marazzi I, Wilson P, Coste H, White J, Kirilovsky J, Rice CM, Lora JM, Prinjha RK, Lee K, Tarahovsky A (2010) Suppression of inflammation by a synthetic histone mimic. Nature 468:1119–1123
Ottinger M, Christalla T, Nathan K, Brinkmann MM, Viejo-Borbolla A, Schulz TF (2006) Kaposi’s sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-Induced G1 cell cycle arrest. J Virol 80(21):10772–10786
Ottinger M, Pliquet D, Christalla T, Frank R, Stewart JP, Schulz TF (2009) The interaction of the gammaherpesvirus 68 orf73 protein with cellular BET proteins affects the activation of cell cycle promoters. J Virol 83(9):4423–4434
Owen DJ, Ornaghi P, Yang J-C, Lowe N, Evans PR, Ballario P, Neuhaus D, Filetici P, Travers AA (2000) The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase Gcn5p. EMBO J 19(22):6141–6149
Picaud S, Costa DD, Thanasopoulou A, Filippakopoulos P, Fish PV, Philpott M, Fedorov O, Brennan P, Bunnage ME, Owen DR, Bradner JE, Taniere P, O’Sullivan B, Muller S, Schwaller J, Stankovic T, Knapp S (2013a) PFI-1, a highly selective protein interaction inhibitor targeting BET bromodomains. Cancer Res 73(11):3336–3346
Picaud S, Wells C, Felletar I, Brotherton D, Martin S, Savitsky P, Diez-Dacal B, Philpott M, Bountra C, Lingard H, Fedorov O, Muller S, Brennan PE, Knapp S, Filippakopoulos P (2013b) RVX-208, an inhibitor of BET transcriptional regulators with selectivity for the second bromodomain. Proc Natl Acad Sci. doi:10.1073/pnas.1310658110
Plotnikov AN, Yang S, Zhou TJ, Rusinova E, Frasca A, Zhou M-M (2014) Structural insights into acetylated-histone H4 recognition by the bromodomain-PHD finger module of human transcriptional coactivator CBP. Structure 22:353–360
Presnell SR, Cohen FE (1989) Topological distribution of four-alpha-helix bundles. Proc Natl Acad Sci USA 86:6592–6596
Price DH (2000) P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol Cell Biol 20(8):2629–2634
Prinjha RK, Witherington J, Lee K (2012) Place your BETs: the therapeutic potential of bromodomains. Trends Pharmacol Sci 33(3):146–153
Puissant A, Frumm SM, Alexe G, Bassil CF, Qi J, Chanthery YH, Nekritz EA, Zeid R, Gustafson WC, Greninger P, Garnett MJ, McDermott U, Benes CH, Kung AL, Weiss WA, Bradner JE, Stegmaier K (2013) Targeting MYCN in neuroblastoma by BET bromodomain inhibition. Cancer Discov 3(3):308–323
Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA, Wysocka J (2011) A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470(7333):279–283
Ragvin A, Valvatne H, Erdal S, Arskog V, Tufteland KR, Breen K, Oyan AM, Eberharter A, Gibson TJ, Becker PB, Aasland R (2004) Nucleosome binding by the bromodomain and PHD finger of the transcriptional cofactor p300. J Mol Biol 337:773–788
Rahman S, Sowa ME, Ottinger M, Smith JA, Shi Y, Harper JW, Howley PM (2011) The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3. Mol Cell Biol 31(13):2641–2652
Richardson JS (1981) The anatomy and taxonomy of protein structure. Adv Prot Chem 34:167–339
Rodriguez RM, Huidoboro C, Urdinguio RG, Mangas C, Soldevilla B, Dominguez G, Bonilla F, Fernandez AF, Fraga MF (2012) Aberrant epigenetic regulation of bromodomain Brd4 in human colon cancer. J Mol Med 90:587–595
Ruthenburg AJ, Li H, Patel DJ, Allis CD (2007) Multivalent engagement of chromatin modifications by linked binding modules. Nat Rev Mol Cell Biol 8:983–994
Ruthenburg AJ, Li H, Milne TA, Dewell S, McGinty RK, Yuen M, Ueberheide B, Dou Y, Muir TW, Patel DJ, Allis CD (2011) Recognition of a mononucleosomal histone modification pattern by BPTF via multivalent interactions. Cell 145:692–706
Sachchidanand, Resnick-Silverman L, Yan S, Mujtaba S, Liu W-j, Zeng L, Manfredi JJ, Zhou M-M (2006) Target structure-based discovery of small molecules that block human p53 and CREB binding protein association. Chem Biol 3:81–90
Sanchez R, Zhou M-M (2009) The role of human bromodomains in chromatin biology and gene transcription. Curr Opin Drug Discov Devel 12(5):659–665
Sanchez R, Zhou M-M (2011) The PHD finger: a versatile epigenome reader. Trends Biochem Sci 36(7):364–72; PubMed Central PMCID: PMC3130114
Sanchez R, Pieper U, Melo F, Eswar N, Marti-Renom MA, Madhusudhan MS, Mirkovic N, Sali A (2000) Protein structure modeling for structural genomics. Nat Struct Biol, Struct Genomics 7: 986–990
Santos-Rosa H, Schneider R, Bannister AJ, Sherriff J, Bernstein BE, Emre NCT, Schreiber SL, Mellor J, Kouzarides T (2002) Active genes are tri-methylated at K4 of histone H3. Nature 419(6905):407–411
Schultz J, Copley RR, Doerks T, Ponting CP, Bork P (2000) SMART: a web-based tool for the study of genetically mobile domains. Nucleic Acids Res 28(1):231–234
Seal J, Lamotte Y, Donche F, Bouillot A, Mirguet O, Gellibert F, Nicodeme E, Krysa G, Kirilovsky J, Beinke S, McCleary S, Rioja I, Bamborough P, Chung C-w, Gordon L, Lewis T, Walker AL, Cutler L, Lugo D, Wilson DM, Witherington J, Lee K, Prinjha RK (2012) Identification of a novel series of BET family bromodomain inhibitors: binding mode and profile of I-BET151 (GSK1210151A). Bioorg Med Chem 22:2968–2972
Seet BT, Dikic I, Zhou M-M, Pawson T (2006) Reading protein modifications with interaction domains. Nat Rev Mol Cell Biol 7:473–483
Shi J, Wang Y, Zeng L, Wu Y, Deng J, Zhang Q, Lin Y, Li J, Kang T, Tao M, Rusinova E, Zhang G, Wang C, Zhu H, Yao J, Zeng Y-X, Evers BM, Zhou M-M, Zhou BP (2014) Disrupting the Interaction of BRD4 with diacetylated twist suppresses tumorigenesis in basal-like breast cancer. Cancer Cell 25:210–225
Simon JA, Kingston RE (2009) Mechanisms of Polycomb gene silencing: knowns and unknowns. Nat Rev Mol Cell Biol 10(10):697–708
Simon JA, Kingston RE (2013) Occupying chromatin: polycomb mechanisms for getting to genomic targets, stopping transcriptional traffic, and staying put. Mol Cell 49(5):808–24; PubMed Central PMCID: PMC3628831
Smith SG, Sanchez R, Zhou M-M (2014) Privileged diazepine compounds and their emergence as bromodomain inhibitors. Chem Biol Epub 15 April 2014. doi: 10.1016/j.chembiol.2014.03.004
Strahl BD, Allis CD (2000) The language of covalent histone modifications. Nature 403(6765):41–45
Tanaka Y, Katagiri Z-i, Kawahashi K, Kioussis D, Kitajima S (2007) Trithorax-group protein ASH1 methylates histone H3 lysine 36. Gene 397:161–168
Taverna SD, Li H, Ruthenburg AJ, Allis CD, Patel DJ (2007) How chromatin-binding modules interpret histone modifications: lessons from professional pocket pickers. Nat Struct Mol Biol 14(11):1025–1040
Thompson M (2009) Polybromo-1: the chromatin targeting subunit of the PBAF complex. Biochimie 91:309–319
Tsai W-W, Wang Z, Yiu TT, Akdemir KC, Xia W, Winter S, Tsai C-Y, Shi X, Schwarzer D, Plunkett W, Aronow B, Gozani O, Fischle W, Hung M-C, Patel DJ, Barton MC (2010) TRIM24 links a non-canonical histone signature to breast cancer. Nature 468(7326):927–932
Van Demark AP, Kasten MM, Ferris E, Heroux A, Hill CP, Cairns BR (2007) Autoregulation of the Rsc4 tandem bromodomain by Gcn5 acetylation. Mol Cell 27(5):817–828
Vignali M, Hassan AH, Neely KE, Workman JL (2000) ATP-dependent chromatin-remodeling complexes. Mol Cell Biol 20(6):1899–1910
Wang GG, Allis CD, Chi P (2007) Chromatin remodeling and cancer, part I: covalent histone modifications. Trends Mol Med 13(9):363–372
Weber PC, Salemme FR (1980) Structural and functional diversity in 4-alpha-helical proteins. Nature 287:82–84
Wu S-Y, Chiang C-M (2007) The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation. J Biol Chem 282(18):13141–13145
Wu S-Y, Lee A-Y, Hou SY, Kemper JK, Erdjument-Bromage H, Tempst P, Chiang C-M (2006) Brd4 links chromatin targeting to HPV transcriptional silencing. Genes Dev 20:2383–2396
Wu S-Y, Lee A-Y, Lai H-T, Zhang H, Chiang C-M (2013) Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting. Mol Cell 49:843–857
Wyspianska B, Bannister A, Barbieri I, Nangalia J, Godfrey A, Calero-Nieto F, Robson S, Rioja I, Li J, Wiese M, Cannizzaro E, Dawson M, Huntly B, Prinjha R, Green A, Gottgens B, Kouzarides T (2013) BET protein inhibition shows efficacy against JAK2V617F-driven neoplasms. Leukemia 28(1):88–97
Xi Q, Wang Z, Zaromytidou A-I, Zhang XH-F, Chow-Tsang L-F, Liu JX, Kim H, Barlas A, Manova-Todorova K, Kaartinen V, Studer L, Mark W, Patel DJ, Massague J (2011) A poised chromatin platform for TGF-B access to master regulators. Cell 147:1511–1524
Yan J, Li Q, Lievens S, Tavernier J, You J (2010) Abrogation of the Brd4-positive transcription elongation factor b complex by papillomavirus E2 protein contributes to viral oncogene repression. J Virol 84(1):76–87
Yang Z, Yik JHN, Chen R, He N, Jang MK, Ozato K, Zhou Q (2005) Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol Cell 19:535–545
Yap KL, Zhou M-M (2006) Structure and function of protein modules in chromatin biology. Results Probl Cell Differ 41:1–23
Yap KL, Li S, Munoz-Cabello AM, Raguz S, Zeng L, Mujtaba S, Gil J, Walsh MJ, Zhou M-M (2010) Molecular Interplay of the noncoding RNA ANRIL and methylated histone H3 lysine 27 by polycomb CBX7 in transcriptional silencing of INK4a. Mol Cell 38(5):662–74; PubMed Central PMCID: PMC2886305
You J, Li Q, Wu C, Kim J, Ottinger M, Howley PM (2009) Regulation of aurora B expression by the bromodomain protein Brd4. Mol Cell Biol 29(18):5094–5103
Young RA (2011) Control of the embryonic stem cell state. Cell 144:940–954
Zeng L, Li J, Muller M, Yan S, Mujtaba S, Pan C, Wang Z, Zhou M-M (2005) Selective small molecules blocking HIV-1 Tat and coactivator PCAF association. J Amer Chem Soc 127:2376–2377
Zeng L, Yap KL, Ivanov AV, Wang X, Mujtaba S, Plotnikova O III (2008) FJR, Zhou M-M. Structural insights into human KAP1 PHD finger-bromodomain and its role in gene silencing. Nat Struct Mol Biol 15(6):626–633
Zhang G, Liu R, Zhong Y, Plotnikov AN, Zhang W, Zeng L, Rusinova E, Gerona-Navarro G, Moshkina N, Joshua J, Chuang PY, Ohlmeyer M, He JC, Zhou M-M (2012) Down-regulation of NF-κB transcriptional activity in HIV-associated kidney disease by BRD4 inhibition. J Biol Chem 287(34):28840–28851; PubMed Central PMCID: PMC3436579
Zhang G, Plotnikov AN, Rusinova E, Shen T, Morohashi K, Joshua J, Zeng L, Mujtaba S, Ohlmeyer M, Zhou M-M (2013) Structure-guided design of potent diazobenzene inhibitors for the BET bromodomains. J Med Chem 56:9251–9264
Zhao R, Nakamura T, Fu Y, Lazar Z, Spector DL (2011) Gene bookmarking accelerates the kinetics of post-mitotic transcriptional re-activation. Nat Cell Biol 13(11):1295–1304
Zhou M-M, Aggarwal AK, Verdin E, Ott M (2004) Inventors methods of identifying modulators of bromodomains. USA (2004)
Zhou M, Huang K, Jung K-J, Cho W-K, Klase Z, Kashanchi F, Pise-Masison CA, Brady JN (2009) Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29. J Virol 83(2):1036–1044
Zou JX, Revenko AS, Li LB, Gemo AT, Chen H-W (2007) ANCCA, an estrogen-regulated AAA+AT pase coactivator for ER-alpha, is required for coregulator occupancy and chromatin modification. Proc Natl Acad Sci USA 104(46):18067–18072
Zou JX, Guo L, Revenko AS, Tepper CG, Gemo AT, Kung H-J, Chen H-W (2009) Androgen-induced coactivator ANCCA mediates specific androgen receptor signaling in prostate cancer. Cancer Res 69(8):3339–3346
Zuber J, Shi J, Wang E, Rappaport AR, Herrmann H, Sison EA, Magoon D, Qi J, Blatt K, Wunderlich M, Taylor MJ, Johns C, Chicas A, Mulloy JC, Kogan SC, Brown P, Valent P, Bradner JE, Lowe SW, Vakoc CR (2011) RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 478:524–528; PubMed Central PMCID: PMC3328300
Acknowledgments
We wish to acknowledge the members of the Zhou Group for helpful discussion. This work was supported in part by the research grants from the National Institutes of Health (to M.-M.Z.).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Smith, S.G., Zhou, MM. (2015). The Bromodomain as the Acetyl-Lysine Binding Domain in Gene Transcription. In: Zhou, MM. (eds) Histone Recognition. Springer, Cham. https://doi.org/10.1007/978-3-319-18102-8_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-18102-8_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-18101-1
Online ISBN: 978-3-319-18102-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)